Innovative direct introduction‐ion mobility–mass spectrometry (DI‐IM‐MS) approach for fast and robust isomer‐specific quantification in a complex matrix: Application to 2′‐fucosyllactose (2’‐FL) in breast milk
Journal of Mass Spectrometry · 2024-05 · 59 (5) · 1-76
DOI: 10.1002/jms.5026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Mass Spectrometry, online erschienen am 24.04.2024. Verfasst von Estelle Rathahao-Paris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, MetaboHUB, Gif-sur-Yvette, France. Hauptthemen laut MEDLINE: Milk, Human, Trisaccharides, Oligosaccharides, Ion Mobility Spectrometry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MetaboHUB.
Themen: Mobilisation
Abstract (Originalsprache)
Identification and specific quantification of isomers in a complex biological matrix by mass spectrometry alone is not an easy task due to their identical chemical formula and therefore their same mass‐to‐charge ratio ( m/z ). Here, the potential of direct introduction combined with ion mobility–mass spectrometry (DI‐IM‐MS) for rapid quantification of isomers as human milk oligosaccharides (HMOs) was investigated. Differences in HMO profiles between various analyzed breast milk samples were highlighted using the single ion mobility monitoring (SIM 2 ) acquisition for high ion mobility resolution detection. Furthermore, the Se+ (secretor) or Se− (non‐secretor) phenotype could be assigned to breast milk samples studied based on their HMO contents, especially on the response of 2′‐fucosyllactose (2’‐FL) and lacto‐N‐fucopentaose I (LNFP I). The possibility of quantifying a specific isomer in breast milk by DI‐IM‐MS was also investigated. The standard addition method allowed the determination of the 2’‐FL despite the presence of other oligosaccharides, including 3‐fucosyllactose (3‐FL) isomer in breast milk. This proof‐of‐concept study demonstrated the high potential of such an approach for the rapid and convenient quantification of isomers in complex mixtures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, MetaboHUB, Gif-sur-Yvette, France.
- Sorbonne Université, Faculté des Sciences et de l'Ingénierie, Institut Parisien de Chimie Moléculaire (IPCM), Paris, France.
- Muséum national d'Histoire naturelle, MCAM, UMR7245 CNRS - MNHN, Paris, France.
ORCID-Profile: Estelle Rathahao-Paris, Sandra Alves
Förderung
- MetaboHUB
Zitieren
APA
Rathahao-Paris, E., Abdoun, S., Paris, A., Guillon, B., Venot, E., Fenaille, F., Adel-Patient, K., & Alves, S. (2024). Innovative direct introduction‐ion mobility–mass spectrometry (DI‐IM‐MS) approach for fast and robust isomer‐specific quantification in a complex matrix: Application to 2′‐fucosyllactose (2’‐FL) in breast milk. Journal of Mass Spectrometry, 59(5), 1-76. https://doi.org/10.1002/jms.5026
Vancouver
Rathahao-Paris E, Abdoun S, Paris A, Guillon B, Venot E, Fenaille F, et al. Innovative direct introduction‐ion mobility–mass spectrometry (DI‐IM‐MS) approach for fast and robust isomer‐specific quantification in a complex matrix: Application to 2′‐fucosyllactose (2’‐FL) in breast milk. Journal of Mass Spectrometry. 2024;59(5):1-76. doi:10.1002/jms.5026
BibTeX
@article{RathahaoParis2024,
author = {Rathahao-Paris, Estelle and Abdoun, Sarah and Paris, Alain and Guillon, Blanche and Venot, Eric and Fenaille, François and Adel-Patient, Karine and Alves, Sandra},
title = {Innovative direct introduction‐ion mobility–mass spectrometry (DI‐IM‐MS) approach for fast and robust isomer‐specific quantification in a complex matrix: Application to 2′‐fucosyllactose (2’‐FL) in breast milk},
journal = {Journal of Mass Spectrometry},
year = {2024},
volume = {59},
number = {5},
pages = {1--76},
doi = {10.1002/jms.5026}
}
EUVIMED